AR009638A1 - Un procedimiento para la determinacion de un anticuerpo de la clase de inmunoglobulina m especifico contra antigenos - Google Patents

Un procedimiento para la determinacion de un anticuerpo de la clase de inmunoglobulina m especifico contra antigenos

Info

Publication number
AR009638A1
AR009638A1 ARP970105577A ARP970105577A AR009638A1 AR 009638 A1 AR009638 A1 AR 009638A1 AR P970105577 A ARP970105577 A AR P970105577A AR P970105577 A ARP970105577 A AR P970105577A AR 009638 A1 AR009638 A1 AR 009638A1
Authority
AR
Argentina
Prior art keywords
determination
antigen
class
procedure
antibody
Prior art date
Application number
ARP970105577A
Other languages
English (en)
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of AR009638A1 publication Critical patent/AR009638A1/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Se refiere a un procedimiento para la determinacion de anticuerpos de la clase de la inmunoglobulina M específicos contra antígenos en presenciade inmunoglobulinas de la clase G y/o factores reumatoides en fluidos corporales por incubacion con lo menos dos diferentes receptores R1 y R2 yopcionalmente receptores adicionales, siendo un componente esencial de R2 una parte ligante en forma polímera y en donde anticuerpos IgG de igualespecificidad contra antígenos son suprimidospor partes ligantes en forma monomera; un reactivo pra determinar un anticuerpo de la clase deinmunoglobulina M específico contra antígenos así como también el uso de partes ligantes en forma monomera para la supresion de anticuerpos IgG duranteladeterminacion de anticuerpo IgM específicos contra antígenos.
ARP970105577A 1996-11-29 1997-11-27 Un procedimiento para la determinacion de un anticuerpo de la clase de inmunoglobulina m especifico contra antigenos AR009638A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19649389A DE19649389A1 (de) 1996-11-29 1996-11-29 Antigenspezifischer IgM-Nachweis

Publications (1)

Publication Number Publication Date
AR009638A1 true AR009638A1 (es) 2000-04-26

Family

ID=7813066

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970105577A AR009638A1 (es) 1996-11-29 1997-11-27 Un procedimiento para la determinacion de un anticuerpo de la clase de inmunoglobulina m especifico contra antigenos

Country Status (18)

Country Link
US (1) US6489129B1 (es)
EP (1) EP0944832B1 (es)
JP (1) JP3958797B2 (es)
KR (1) KR20000057315A (es)
CN (1) CN1245560A (es)
AR (1) AR009638A1 (es)
AT (1) ATE204082T1 (es)
AU (1) AU720123B2 (es)
BR (1) BR9714365A (es)
CA (1) CA2272302A1 (es)
DE (2) DE19649389A1 (es)
ES (1) ES2162347T3 (es)
IL (1) IL130112A0 (es)
NO (1) NO992579L (es)
NZ (1) NZ335754A (es)
TW (1) TW434405B (es)
WO (1) WO1998023955A2 (es)
ZA (1) ZA9710726B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10009503A1 (de) * 2000-02-29 2001-08-30 Roche Diagnostics Gmbh Verfahren zur Immobilisierung von Konjugaten in diagnostischen Tests
US7262019B2 (en) * 2001-05-03 2007-08-28 Immunetics, Inc. System and methods for detection of Bacillus anthracis related analytes in biological fluids
WO2002090961A2 (en) * 2001-05-03 2002-11-14 Immunetics, Inc. Systems and methods for detection of analytes in biological fluids
US7387890B2 (en) * 2004-12-16 2008-06-17 Chembio Diagnostic Systems, Inc. Immunoassay devices and use thereof
US7189522B2 (en) 2005-03-11 2007-03-13 Chembio Diagnostic Systems, Inc. Dual path immunoassay device
WO2006098804A2 (en) 2005-03-11 2006-09-21 Chembio Diagnostic Systems, Inc. Dual path immunoassay device
ES2372359T3 (es) 2007-04-20 2012-01-19 F. Hoffmann-La Roche Ag Detección de infecciones primarias por patógenos.
US20100022916A1 (en) 2008-07-24 2010-01-28 Javanbakhsh Esfandiari Method and Apparatus for Collecting and Preparing Biological Samples for Testing
CA2793959C (en) 2010-03-25 2019-06-04 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
US8603835B2 (en) 2011-02-10 2013-12-10 Chembio Diagnostic Systems, Inc. Reduced step dual path immunoassay device and method
HUE037408T2 (hu) 2011-06-10 2018-08-28 Univ Oregon Health & Science CMV glikoproteinek és rekombináns vektorok
AU2012216792A1 (en) 2011-09-12 2013-03-28 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies
EP2586461A1 (en) 2011-10-27 2013-05-01 Christopher L. Parks Viral particles derived from an enveloped virus
CN102507932A (zh) * 2011-12-02 2012-06-20 无锡博慧斯生物医药科技有限公司 一种IgM抗体检测试纸条
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
ES2906853T3 (es) 2014-04-02 2022-04-20 Chembio Diagnostic Systems Inc Inmunoensayo que utiliza conjugado de atrapamiento
US20160116466A1 (en) 2014-10-27 2016-04-28 Chembio Diagnostic Systems, Inc. Rapid Screening Assay for Qualitative Detection of Multiple Febrile Illnesses
EP3069730A3 (en) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
EP3072901A1 (en) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
EP3176580A1 (en) * 2015-12-01 2017-06-07 Roche Diagnostics GmbH Method for reduction of interferences in immunoassays
CN105759059A (zh) * 2016-04-27 2016-07-13 丹娜（天津）生物科技有限公司 一种检测EV71病毒IgM抗体的免疫检测试剂盒及其制备方法
CN105974111B (zh) * 2016-07-20 2019-07-09 国家纳米科学中心 一种类风湿因子(IgM型)及其他抗原特异性IgM抗体联合检测的方法
CN107656057A (zh) * 2017-09-06 2018-02-02 中国农业科学院兰州兽医研究所 一种用于检测布鲁氏杆菌病IgM抗体的ELISA试剂盒及其应用
WO2020061135A1 (en) * 2018-09-18 2020-03-26 Siemens Healthcare Diagnostics Inc. Methods and reagents for zika virus immunoassays
CN113495141A (zh) * 2020-03-20 2021-10-12 迈克生物股份有限公司 2019新型冠状病毒IgM抗体检测试剂盒

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL80129A0 (en) * 1986-09-23 1986-12-31 Savyon Diagnostics Ltd Method for the determination of igm and iga immunoglobulins and reagents therefor
DE3705686C2 (de) * 1987-02-23 1995-11-30 Boehringer Mannheim Gmbh Verfahren zur Bestimmung von Antikörpern
SE8701628D0 (sv) * 1987-04-16 1987-04-16 Erling Norrby Medel for analys mm
DE3717401A1 (de) * 1987-05-23 1988-12-08 Behringwerke Ag Einschritt-immuntest zur bestimmung von antigen-spezifischen antikoerpern aus einer der immunglobulin-klassen a, m, d oder e und dazu geeignetes mittel
US6613530B1 (en) 1994-07-25 2003-09-02 Roche Diagnostics Gmbh Determination of a specific immunoglobulin using multiple antigens
NZ291155A (en) * 1994-07-25 1997-09-22 Boehringer Mannheim Gmbh Production of hapten labelled peptides and their use
DE4439452A1 (de) * 1994-11-04 1996-05-09 Boehringer Mannheim Gmbh Antikörperklassenspezifisches Entstörungsreagenz

Also Published As

Publication number Publication date
JP3958797B2 (ja) 2007-08-15
DE19649389A1 (de) 1998-06-04
NZ335754A (en) 2001-05-25
NO992579L (no) 1999-07-28
JP2001506749A (ja) 2001-05-22
ES2162347T3 (es) 2001-12-16
IL130112A0 (en) 2000-06-01
US6489129B1 (en) 2002-12-03
DE59704261D1 (de) 2001-09-13
EP0944832A2 (de) 1999-09-29
WO1998023955A2 (de) 1998-06-04
WO1998023955A3 (de) 1998-07-23
CA2272302A1 (en) 1998-06-04
EP0944832B1 (de) 2001-08-08
BR9714365A (pt) 2000-03-21
NO992579D0 (no) 1999-05-28
ZA9710726B (en) 1999-05-28
AU5751398A (en) 1998-06-22
ATE204082T1 (de) 2001-08-15
AU720123B2 (en) 2000-05-25
CN1245560A (zh) 2000-02-23
TW434405B (en) 2001-05-16
KR20000057315A (ko) 2000-09-15

Similar Documents

Publication Publication Date Title
AR009638A1 (es) Un procedimiento para la determinacion de un anticuerpo de la clase de inmunoglobulina m especifico contra antigenos
AR009636A1 (es) Un metodo para la determinacion de un anticuerpo de la clase de inmunoglobulina g especifico contra antigenos.
DK1232392T3 (da) Forbedret fremgangsmåde til påvisning af syreresistente bakterier af slægten Helicobacter i afføring
DE69221147D1 (de) Nicht glycosylierter Anti-CD3-IgG-Antikörper
DE60042789D1 (de) Immobilisierte antigenbindende moleküle aus einer domäne
DE58906981D1 (de) Verfahren zur Bestimmung einer spezifisch bindefähigen Substanz.
DE69808609T2 (de) Antagonistische anti-avb3 integrin antikörper
IL83113A (en) Bifunctional antibodies having antigen specificity for fc receptor and for an epitope of a target cell
SE7602834L (sv) Diagnotiskt reagenssystem
DK0595798T3 (da) Bispecifikke heteroantistoffer med dobbelte effektorfunktioner
AU619183B2 (en) A one-step immunoassay for the determination of antigen-specific antibodies of one of the immunoglobulin classes a,m,d or e, and an agent suitable for this purpose
MX9401112A (es) Preparacion de conjugados de fotoproteina y metodos para utilizar los mismos.
ATE161581T1 (de) Monoklonale antikörper gegen humane pankreas- inselzellen
ATE254286T1 (de) Zwei-inkubations mit markiertem antigen verwendenes immunoassay
AU2003248619A1 (en) Method for the elimination of interferences in immunochromatographic assays
PT733903E (pt) Processo de dosagem imunologica de cortisol nomeadamente urinario e reagentes utilizados
WO2002076406A3 (en) Antibodies against autoantigens of primary biliary cirrhosis and methods of making and using them
GR3030212T3 (en) Platelet activating factor antagonists.
ATE174060T1 (de) Monoklonale antikörper gegen mutmassliche hepatitis c-virus ns5-proteine und ihre anwendungsmethoden
EA201992039A1 (ru) Антитела к tigit
ATE281471T1 (de) Antikörper-testbesteck zur bestimmung von amylin
DE60029570D1 (de) Verfahren zur isolierung der cd8+-zellen, und entsprechende hybridomazellen, antikörper und polypeptide
BG50337A1 (en) Hybridom cellular line secreting a monoclonal anti-body against insulin
NZ314010A (en) A method of targeting intracellular binding proteins using a lipidized antibody